VANCOUVER, BC / ACCESS Newswire / February 3, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases ...
Lotfy, A. (2026) A Digital Accounting Framework for Enhancing Solvency and Financial Evaluation in Non-Bank Financial ...
Photo courtesy of Kumanan Beyond governance failures, the economic picture remained deeply troubling as 2025 drew to a close.
In the world of modern medicine, most people focus on the active pharmaceutical ingredients, which are the chemicals that ...
VANCOUVER, BC / ACCESS Newswire / January 21, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report final results from a preclinical pig study ...
Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2025" report has been added to ResearchAndMarkets.com's offering. The clinical trial ...
Clinical trial results showed an objective response rate of 75% (95% CI, 64-83), with 59% of patients having a complete response and 16% having a partial response. The Food and Drug Administration ...
The Justice Department said on Tuesday it will no longer investigate accusations of systemic racism or sexism, drastically limiting how college students, parents, and employees can accuse a university ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results